Last Updated: July 25, 2026

LARIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Larin, and when can generic versions of Larin launch?

Larin is a drug marketed by Novast Labs and is included in five NDAs.

The generic ingredient in LARIN is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for LARIN?
  • What are the global sales for LARIN?
  • What is Average Wholesale Price for LARIN?
Summary for LARIN
US Patents:0
Applicants:1
NDAs:5
Drug Prices: Drug price information for LARIN
Drug Sales Revenues: Drug sales revenues for LARIN
DailyMed Link:LARIN at DailyMed
Drug patent expirations by year for LARIN
Drug Prices for LARIN

See drug prices for LARIN

Drug Sales Revenue Trends for LARIN

See drug sales revenues for LARIN

US Patents and Regulatory Information for LARIN

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs LARIN 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 202996-001 Mar 20, 2014 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novast Labs LARIN FE 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 091453-001 Aug 23, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novast Labs LARIN 1/20 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 202995-001 Dec 4, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novast Labs LARIN 24 FE ethinyl estradiol; norethindrone acetate TABLET;ORAL 202994-001 Feb 18, 2015 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novast Labs LARIN FE 1/20 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 091454-001 Aug 26, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links